Sanara MedTech Inc.
SMTI
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biakos Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extrā¦ read more
Healthcare
Medical Instruments & Supplies
31 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$23.51
Price+0.66%
$0.16
1Y
Price
Market Cap
$210.022m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-106.3%
EBITDA Margin-115.5%
Net Profit Margin+4.2%
Free Cash Flow Margin-106.3%
EBITDA Margin-115.5%
Net Profit Margin+4.2%
Free Cash Flow MarginRevenue
$101.904m
+17.6%
1y CAGR+30.9%
3y CAGR+45.6%
5y CAGREarnings
-$37.491m
-287.9%
1y CAGR-122.2%
3y CAGR-91.7%
5y CAGREPS
-$0.73
+36.0%
1y CAGR-11.8%
3y CAGR-7.0%
5y CAGRBook Value
$6.132m
$71.089m
Assets$64.948m
Liabilities$47.392m
DebtDebt to Assets
66.7%
-1.8x
Debt to EBITDAFree Cash Flow
-$865.500k
-242.0%
1y CAGR-35.0%
3y CAGR-29.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company